Kalium-Natrium-Glucose Braun নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kalium-natrium-glucose braun

b. braun melsungen ag - glukosemonohydrat / natriumklorid / kaliumklorid - infusjonsvæske, oppløsning - 50 mg/ ml / 2.3 mg/ ml / 1.5 mg/ ml

Palonosetron Fresenius Kabi 250 mikrog নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

palonosetron fresenius kabi 250 mikrog

fresenius kabi norge as - palonosetronhydroklorid - injeksjonsvæske, oppløsning - 250 mikrog

Ringer-Acetat Braun 0.203 g/ L / 0.294 g/ L / 0.298 g/ L / 4.08 g/ L / 5.84 g/ L নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ringer-acetat braun 0.203 g/ l / 0.294 g/ l / 0.298 g/ l / 4.08 g/ l / 5.84 g/ l

b. braun melsungen ag - magnesiumklorid / kalsiumklorid / kaliumklorid / natriumacetat / natriumklorid - infusjonsvæske, oppløsning - 0.203 g/ l / 0.294 g/ l / 0.298 g/ l / 4.08 g/ l / 5.84 g/ l

Salidex 2.92 g/ L / 35 g/ L নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

salidex 2.92 g/ l / 35 g/ l

b. braun melsungen ag - natriumklorid / glukose - infusjonsvæske, oppløsning - 2.92 g/ l / 35 g/ l

Warfarin Orion 2.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

warfarin orion 2.5 mg

orion corporation - espoo - warfarinnatrium - tablett - 2.5 mg

Xenetix 350 mg I/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

xenetix 350 mg i/ ml

guerbet - jobitridol - injeksjonsvæske, oppløsning - 350 mg i/ ml

Xenetix 250 mg I/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

xenetix 250 mg i/ ml

guerbet - jobitridol - injeksjonsvæske, oppløsning - 250 mg i/ ml

Xenetix 300 mg I/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

xenetix 300 mg i/ ml

guerbet - jobitridol - injeksjonsvæske, oppløsning - 300 mg i/ ml

Zyban 150 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

zyban 150 mg

2care4 - bupropionhydroklorid - depottablett - 150 mg

Thiotepa Riemser ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.